§ BIOTECHNOLOGY
USD · BiotechnologyDMAC
DIAMEDICA THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
46 increased/new, 24 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| COOPERMAN LEON G | 2.0M | 0.4% | ±0% |
| BlackRock, Inc. | 1.9M | 0.0% | −2% |
| Millennium Management | 936K | 0.0% | +22% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 875K | 8.1% | ±0% |
| Geode Capital Management | 781K | 0.0% | +2% |
| State Street | 644K | 0.0% | +3% |
◇ AC INTELLIGENCE
Top institutional owners for DMAC as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER76.7% · 0 holders
OTHER11.9% · 62 holders
PASSIVE / INDEX5.4% · 7 holders
DEALER / BANK2.7% · 18 holders
TACTICAL / MACRO2.1% · 2 holders
DEEP VALUE0.9% · 1 holder
QUALITY / COMPOUNDER0.2% · 3 holders
SYSTEMATIC / QUANT0.1% · 2 holders
INCOME / DEFENSIVE0.0% · 4 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for DMAC in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention DMAC yet.